Goldman Sachs Sees Broad EPS Pressure Across Capital Markets, Highlights Brookfield As A Standout Goldman Sachs analyst expects uncertainty and low rates to impact EPS forecasts for Capital Markets stocks. Alternatives face EPS risks, while Brokers and Wealth Advisors may see downside. Traditional Managers also at risk.
Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks.
Can Carnival Stock Cruise Higher Next Week? The largest cruise line operator has a big earnings report to announce before the next opening bell.
Why Penumbra Stock Zoomed Nearly 5% Higher Today The company might just be the right kind of business operating at the right time in history.
Why Relay Therapeutics Plummeted by Nearly 14% Today Investors weren't happy with the company's latest effort at capital-raising.
Here's Why Birkenstock Stock Dropped Nearly 16% Last Month When valuations are high, even little things can lead to disappointment.
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell? Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies.
